Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...
MedPage Today on MSN
MicroRNA tests eyed for flagging heart transplant rejection
Panels designed to identify acute cellular rejection, antibody-mediated rejection without ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...
In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a blood test used to ...
About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung allograft dysfunction (CLAD), the primary cause of mortality after ...
A novel approach to organ transplantation allowed patients to wean off anti-rejection drugs after two years, according to the results of a phase 3 clinical trial presented Monday. The drugs, called ...
Rutgers Health researchers and other medical scientists involved in a large international study have identified new signs of kidney transplant rejection that could lead to more precise diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results